We are a consortium of seven partners with the shared goal of creating an entirely new nanoparticle design platform capable of autonomously evolving solutions for cancer treatment.
EVO-NANO brings together expertise in computer science, artificial evolution, modelling, microfluidics, and medicine.
Build an evolutionary model to simulate all the main aspects of nanoparticle dynamics in the body and tumour environment.
Streamline synthesis of functionalised nanoparticles suggested by the evolutionary model.
Validate efficacy of artificially evolved nanoparticle designs using in vitro micro-fluidics and in vivo pre-clinical tests.
This project has received funding from the European Union's Horizon 2020 FET Open programme under grant agreement. No. 800983.